Home › Calculator › LGVN Dividend Calculator 2026
LGVN Dividend DRIP Calculator 2026
311.04% YieldHealthcareLongeveron Inc. · NASDAQ
Price: $0.64 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When LGVN pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your LGVN snowball 📈
$10,000 in LGVN → $40473071860688680.00M in 10 years · $3,371,697,393,945,261,000,000.00/month
About Longeveron Inc. (LGVN) — Dividend Analysis 2026
Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to pioneering cell-based therapies. These treatments are designed to address both age-related conditions and various critical, life-threatening illnesses. The company's primary investigational product is LOMECEL-B, a sophisticated cellular therapy. This product is created from medicinal signaling cells that are cultivated and expanded after being harvested from the bone marrow of healthy young adult donors. Longeveron is actively conducting Phase 1 and Phase 2 clinical trials to evaluate LOMECEL-B's potential across a diverse range of indications. These include age-related frailty, Alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). Established in 2014, Longeveron Inc. operates from its headquarters in Miami, Florida.
Compare LGVN with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full LGVN DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LGVN position with:
🌍 LGVN Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold LGVN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 311.04% | 308.24% | $31,104 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 264.38% | 261.58% | $26,438 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 248.83% | 246.03% | $24,883 / yr |
| 🇬🇧 UK ISA | 0% | 311.04% | 308.24% | $31,104 / yr |
| 🇬🇧 UK Taxable | 8.75% | 283.82% | 281.02% | $28,382 / yr |
| 🇨🇦 TFSA | 0% | 311.04% | 308.24% | $31,104 / yr |
| 🇨🇦 CA Taxable | 25% | 233.28% | 230.48% | $23,328 / yr |
| 🇦🇺 Super (pension) | 15% | 264.38% | 261.58% | $26,438 / yr |
| 🇦🇺 AU Taxable | 30% | 217.73% | 214.93% | $21,773 / yr |
| 🇩🇪 DE Taxable | 26.375% | 229.00% | 226.20% | $22,900 / yr |
| 🇫🇷 FR Taxable | 30% | 217.73% | 214.93% | $21,773 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 LGVN Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 LGVN Dividend Payment Schedule
LGVN pays quarterly — 4 times per year. Next ex-div: TBD.
📊 LGVN vs Healthcare Benchmarks
How LGVN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LGVN sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ LGVN Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-07-06 | 600,000 | — | — | ||
| A-Award | 2026-07-06 | 400,000 | $0.65 | $260.0K | ||
| F-InKind | 2026-07-01 | 18,046 | $0.73 | $13.2K | ||
| F-InKind | 2026-07-01 | 22,505 | $0.73 | $16.4K | ||
| F-InKind | 2026-07-01 | 22,505 | $0.73 | $16.4K | ||
| F-InKind | 2026-07-01 | 15,808 | $0.73 | $11.5K | ||
| F-InKind | 2026-07-01 | 13,143 | $0.73 | $9.6K | ||
| A-Award | 2026-05-01 | 250,000 | — | — | ||
| A-Award | 2026-05-01 | 500,000 | — | — | ||
| A-Award | 2026-05-01 | 250,000 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LGVN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Longeveron Inc. (LGVN) is currently trading at $0.64, 100% below its 52-week high. The current dividend yield is 311.04% based on an annual payout of $2.00 per share.
LGVN (Longeveron Inc.) — 311.04% Dividend Yield Analysis
Longeveron Inc. (LGVN) is a healthcare stock currently trading at $0.64 with a dividend yield of 311.04%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (311.04%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.